Definitive Statement Details Reverse Merger with Altanine, 80% Ownership Shift, and Major Dilutive Capital Raises

summarizeSummary

Polomar Health Services filed a definitive statement detailing its reverse merger with Altanine Inc., which will result in Altanine shareholders owning 80% of the combined company and a new management team. The plan includes a significant reverse stock split and substantial dilutive capital raises, while the company continues to face 'going concern' doubts.

check_boxKey Events

• Definitive Reverse Merger Approved

  The company finalized the terms of its reverse merger with Altanine Inc., previously announced in a preliminary filing on 2026-02-05. This will result in Altanine shareholders owning approximately 80% of the combined entity, significantly diluting existing Polomar shareholders.

• Management and Board Overhaul

  Altanine's CEO and CFO will assume the same roles in the combined company, and Altanine appointees will hold four of five board seats, marking a clear change in corporate control and strategic direction.

• Reverse Stock Split Planned

  A reverse stock split with a ratio between 1-for-2 and 1-for-100 is authorized, a necessary step to achieve a target share price of $10.00 for a potential Nasdaq listing.

• Significant Dilutive Capital Raises

  Plans include establishing an equity line of credit for up to $25 million and a concurrent private offering of $7-10 million at $10.00 per share, both representing substantial capital infusions that will be highly dilutive to current shareholders.

auto_awesomeAnalysis

This definitive information statement confirms and details the reverse merger with Altanine Inc., a transformational event for Polomar Health Services. The terms are highly dilutive for existing Polomar shareholders, who will own only 20% of the combined entity, while Altanine shareholders will control 80%. This effectively constitutes a change of control, with Altanine's management taking over key executive roles and board seats. The company also outlines plans for a substantial equity line of credit of up to $25 million and a concurrent private offering of $7-10 million, both of which represent significant capital raises relative to Polomar's current market capitalization and will lead to further dilution. A reverse stock split of up to 1-for-100 is planned to meet Nasdaq listing requirements, a common action for low-priced stocks. The filing also reiterates the company's 'going concern' warning, highlighting ongoing financial challenges. Investors should be aware of the profound shift in ownership, control, and business strategy, alongside the substantial dilution and financial risks.